| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACSL1
|
acyl-CoA synthetase long-chain family member 1
|
|
ACTN1
|
actinin, alpha 1
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGK
|
acylglycerol kinase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AIM2
|
absent in melanoma 2
|
|
AJAP1
|
adherens junctions associated protein 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANAPC1
|
anaphase promoting complex subunit 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANXA1
|
annexin A1
|
|
ANXA7
|
annexin A7
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3D
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOM
|
apolipoprotein M
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like)
|
|
ARL2
|
ADP-ribosylation factor-like 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATF6
|
activating transcription factor 6
|
|
ATG7
|
autophagy related 7
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B3GNT1
|
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAIAP2
|
BAI1-associated protein 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BANF1
|
barrier to autointegration factor 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BNIPL
|
BCL2/adenovirus E1B 19kD interacting protein like
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BVES
|
blood vessel epicardial substance
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
CA2
|
carbonic anhydrase II
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CAND1
|
cullin-associated and neddylation-dissociated 1
|
|
CAPN3
|
calpain 3, (p94)
|
|
CAPRIN1
|
cell cycle associated protein 1
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAST
|
calpastatin
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBX5
|
chromobox homolog 5
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC154
|
coiled-coil domain containing 154
|
|
CCK
|
cholecystokinin
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNDBP1
|
cyclin D-type binding-protein 1
|
|
CCNE1
|
cyclin E1
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD7
|
CD7 molecule
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD93
|
CD93 molecule
|
|
CDC42BPA
|
CDC42 binding protein kinase alpha (DMPK-like)
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDHR2
|
cadherin-related family member 2
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5RAP3
|
CDK5 regulatory subunit associated protein 3
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CELF2
|
CUGBP, Elav-like family member 2
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHORDC1
|
cysteine and histidine-rich domain (CHORD) containing 1
|
|
CHRM4
|
cholinergic receptor, muscarinic 4
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CKB
|
creatine kinase, brain
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLDN1
|
claudin 1
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CNGA1
|
cyclic nucleotide gated channel alpha 1
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CRAT
|
carnitine O-acetyltransferase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSG
|
cathepsin G
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CTTN
|
cortactin
|
|
CUEDC2
|
CUE domain containing 2
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DCN
|
decorin
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNAJB8
|
DnaJ (Hsp40) homolog, subfamily B, member 8
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DSG1
|
desmoglein 1
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DUSP9
|
dual specificity phosphatase 9
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
DYSF
|
dysferlin
|
|
E2F1
|
E2F transcription factor 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EBF3
|
early B-cell factor 3
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EDN1
|
endothelin 1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELP3
|
elongator acetyltransferase complex subunit 3
|
|
EN1
|
engrailed homeobox 1
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB3
|
EPH receptor B3
|
|
EPHB4
|
EPH receptor B4
|
|
EPHB6
|
EPH receptor B6
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETF1
|
eukaryotic translation termination factor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAN1
|
FANCD2/FANCI-associated nuclease 1
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I)
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO1
|
flavin containing monooxygenase 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXG1
|
forkhead box G1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GABPB1
|
GA binding protein transcription factor, beta subunit 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GANAB
|
glucosidase, alpha; neutral AB
|
|
GAS1
|
growth arrest-specific 1
|
|
GAST
|
gastrin
|
|
GATA2
|
GATA binding protein 2
|
|
GCG
|
glucagon
|
|
GDF15
|
growth differentiation factor 15
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like
|
|
GPR87
|
G protein-coupled receptor 87
|
|
GPX2
|
glutathione peroxidase 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC6
|
histone deacetylase 6
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HDLBP
|
high density lipoprotein binding protein
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIRA
|
histone cell cycle regulator
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HOXA9
|
homeobox A9
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR3E
|
5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA4
|
interferon, alpha 4
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IGSF11
|
immunoglobulin superfamily, member 11
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL31
|
interleukin 31
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHBA
|
inhibin, beta A
|
|
INPP5K
|
inositol polyphosphate-5-phosphatase K
|
|
INS
|
insulin
|
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JADE1
|
jade family PHD finger 1
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KCMF1
|
potassium channel modulatory factor 1
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCNE4
|
potassium channel, voltage gated subfamily E regulatory beta subunit 4
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF14
|
kinesin family member 14
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLHDC10
|
kelch domain containing 10
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1RE1
|
LINE1 retrotransposable element 1
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LARP4
|
La ribonucleoprotein domain family, member 4
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
|
LCN2
|
lipocalin 2
|
|
LDHB
|
lactate dehydrogenase B
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LINC00467
|
long intergenic non-protein coding RNA 467
|
|
LIPG
|
lipase, endothelial
|
|
LLGL1
|
lethal giant larvae homolog 1 (Drosophila)
|
|
LMNA
|
lamin A/C
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPL
|
lipoprotein lipase
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRRC26
|
leucine rich repeat containing 26
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAB21L1
|
mab-21-like 1 (C. elegans)
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
|
|
MAGED1
|
melanoma antigen family D1
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCO
|
macrophage receptor with collagenous structure
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEOX2
|
mesenchyme homeobox 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR100
|
microRNA 100
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR10A
|
microRNA 10a
|
|
MIR10B
|
microRNA 10b
|
|
MIR122
|
microRNA 122
|
|
MIR1228
|
microRNA 1228
|
|
MIR1246
|
microRNA 1246
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR125B2
|
microRNA 125b-2
|
|
MIR126
|
microRNA 126
|
|
MIR137
|
microRNA 137
|
|
MIR139
|
microRNA 139
|
|
MIR144
|
microRNA 144
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR153-1
|
microRNA 153-1
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR181C
|
microRNA 181c
|
|
MIR182
|
microRNA 182
|
|
MIR195
|
microRNA 195
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR211
|
microRNA 211
|
|
MIR212
|
microRNA 212
|
|
MIR214
|
microRNA 214
|
|
MIR215
|
microRNA 215
|
|
MIR216A
|
microRNA 216a
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MIR27A
|
microRNA 27a
|
|
MIR27B
|
microRNA 27b
|
|
MIR29A
|
microRNA 29a
|
|
MIR29C
|
microRNA 29c
|
|
MIR302A
|
microRNA 302a
|
|
MIR30D
|
microRNA 30d
|
|
MIR30E
|
microRNA 30e
|
|
MIR31
|
microRNA 31
|
|
MIR328
|
microRNA 328
|
|
MIR329-1
|
microRNA 329-1
|
|
MIR330
|
microRNA 330
|
|
MIR34A
|
microRNA 34a
|
|
MIR365A
|
microRNA 365a
|
|
MIR367
|
microRNA 367
|
|
MIR373
|
microRNA 373
|
|
MIR378A
|
microRNA 378a
|
|
MIR379
|
microRNA 379
|
|
MIR424
|
microRNA 424
|
|
MIR451A
|
microRNA 451a
|
|
MIR493
|
microRNA 493
|
|
MIR498
|
microRNA 498
|
|
MIR503
|
microRNA 503
|
|
MIR506
|
microRNA 506
|
|
MIR636
|
microRNA 636
|
|
MIR637
|
microRNA 637
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR96
|
microRNA 96
|
|
MIR99A
|
microRNA 99a
|
|
MIR99B
|
microRNA 99b
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKRN3
|
makorin ring finger protein 3
|
|
MLXIP
|
MLX interacting protein
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOB1A
|
MOB kinase activator 1A
|
|
MPP1
|
membrane protein, palmitoylated 1, 55kDa
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSX1
|
msh homeobox 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC20
|
mucin 20, cell surface associated
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBP
|
MYC binding protein
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1
|
|
NDUFA1
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NES
|
nestin
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIL3
|
nuclear factor, interleukin 3 regulated
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NKIRAS2
|
NFKB inhibitor interacting Ras-like 2
|
|
NKRF
|
NFKB repressing factor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NLK
|
nemo-like kinase
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOC2L
|
nucleolar complex associated 2 homolog (S. cerevisiae)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPPA
|
natriuretic peptide A
|
|
NPPC
|
natriuretic peptide C
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRM
|
nurim (nuclear envelope membrane protein)
|
|
NRP2
|
neuropilin 2
|
|
NT5C1A
|
5'-nucleotidase, cytosolic IA
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
ODAM
|
odontogenic, ameloblast asssociated
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRL1
|
opiate receptor-like 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OSCP1
|
organic solute carrier partner 1
|
|
OSM
|
oncostatin M
|
|
OTUD7A
|
OTU deubiquitinase 7A
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PATL1
|
protein associated with topoisomerase II homolog 1 (yeast)
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBK
|
PDZ binding kinase
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCDH10
|
protocadherin 10
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PHB
|
prohibitin
|
|
PHC3
|
polyhomeotic homolog 3 (Drosophila)
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHF6
|
PHD finger protein 6
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
|
PKMYT1
|
protein kinase, membrane associated tyrosine/threonine 1
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLK3
|
polo-like kinase 3
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLXNC1
|
plexin C1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP4C
|
protein phosphatase 4, catalytic subunit
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PPY
|
pancreatic polypeptide
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM14
|
PR domain containing 14
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRICKLE1
|
prickle homolog 1 (Drosophila)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKD1
|
protein kinase D1
|
|
PROX1
|
prospero homeobox 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTENP1
|
phosphatase and tensin homolog pseudogene 1 (functional)
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTMA
|
prothymosin, alpha
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVR
|
poliovirus receptor
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB5B
|
RAB5B, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF4
|
Ras association (RalGDS/AF-6) domain family member 4
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM38
|
RNA binding motif protein 38
|
|
RBM5
|
RNA binding motif protein 5
|
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
RCVRN
|
recoverin
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RETN
|
resistin
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
REXO1
|
REX1, RNA exonuclease 1 homolog (S. cerevisiae)
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHD
|
Rh blood group, D antigen
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RHOC
|
ras homolog family member C
|
|
RIC8A
|
RIC8 guanine nucleotide exchange factor A
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RNASET2
|
ribonuclease T2
|
|
RNF2
|
ring finger protein 2
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPL11
|
ribosomal protein L11
|
|
RPL29
|
ribosomal protein L29
|
|
RPL30
|
ribosomal protein L30
|
|
RPL5
|
ribosomal protein L5
|
|
RPLP0
|
ribosomal protein, large, P0
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SACK1B
|
scaffolding CK1 anchoring protein B
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCAI
|
suppressor of cancer cell invasion
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCG2
|
secretogranin II
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SCTR
|
secretin receptor
|
|
SDC2
|
syndecan 2
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SENP7
|
SUMO1/sentrin specific peptidase 7
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SERTAD1
|
SERTA domain containing 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
|
SFTPD
|
surfactant protein D
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH2D4A
|
SH2 domain containing 4A
|
|
SH3BGRL
|
SH3 domain binding glutamate-rich protein like
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SKI
|
SKI proto-oncogene
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC7A6
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SP1
|
Sp1 transcription factor
|
|
SP100
|
SP100 nuclear antigen
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STC1
|
stanniocalcin 1
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STMN1
|
stathmin 1
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULF1
|
sulfatase 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUPV3L1
|
suppressor of var1, 3-like 1 (S. cerevisiae)
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
SYT13
|
synaptotagmin XIII
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBCD
|
tubulin folding cofactor D
|
|
TBCEL
|
tubulin folding cofactor E-like
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX18
|
T-box 18
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCEA1
|
transcription elongation factor A (SII), 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TEX101
|
testis expressed 101
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TKTL1
|
transketolase-like 1
|
|
TLK1
|
tousled-like kinase 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TM4SF5
|
transmembrane 4 L six family member 5
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TMEM173
|
transmembrane protein 173
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TNRC6A
|
trinucleotide repeat containing 6A
|
|
TNS4
|
tensin 4
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53I3
|
tumor protein p53 inducible protein 3
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRIM13
|
tripartite motif containing 13
|
|
TRIM65
|
tripartite motif containing 65
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TTK
|
TTK protein kinase
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UCA1
|
urothelial cancer associated 1 (non-protein coding)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UHRF2
|
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
|
|
ULBP2
|
UL16 binding protein 2
|
|
UNC5A
|
unc-5 homolog A (C. elegans)
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP2
|
ubiquitin specific peptidase 2
|
|
USP25
|
ubiquitin specific peptidase 25
|
|
UTS2R
|
urotensin 2 receptor
|
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VENTX
|
VENT homeobox
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VMP1
|
vacuole membrane protein 1
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VWA5A
|
von Willebrand factor A domain containing 5A
|
|
VWCE
|
von Willebrand factor C and EGF domains
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WBP1
|
WW domain binding protein 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB10
|
zinc finger and BTB domain containing 10
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZBTB3
|
zinc finger and BTB domain containing 3
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
|
ZNF331
|
zinc finger protein 331
|
|
ZNF668
|
zinc finger protein 668
|
